ADMINISTRATION of LMP-SPECIFIC CYTOTOXIC T-LYMPHOCYTES to PATIENTS with RELAPSED EBV-POSITIVE LYMPHOMA

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT01956084

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:27:02.131194+00:00

Published At

2024-12-19T00:00:00+00:00

Record Updated At

2024-12-19

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Hodgkin Disease", "Non Hodgkin Lymphoma", "Lymphoepithelioma", "Severe Chronic Active EBV Infection Syndrome (SCAEBV)", "Leiomyosarcoma"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2024-12-19"

protocolSection.identificationModule.nctId

"NCT01956084"

protocolSection.identificationModule.officialTitle

"ADMINISTRATION of LMP-SPECIFIC CYTOTOXIC T-LYMPHOCYTES to PATIENTS with RELAPSED EBV-POSITIVE LYMPHOMA"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE1"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Hodgkin Disease (protocolSection.conditionsModule.conditions)
• Non Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
• Lymphoepithelioma (protocolSection.conditionsModule.conditions)
• Severe Chronic Active EBV Infection Syndrome (SCAEBV) (protocolSection.conditionsModule.conditions)
• Leiomyosarcoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.